News

• Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

  February 11, 2025

• Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

  February 6, 2025

• Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

  February 4, 2025

• Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference

  January 31, 2025

• Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market

  January 30, 2025

• Aclarion Announces Revised Split Ratio and Timing for Reverse Stock Split

  January 28, 2025

• Aclarion Announces Reverse Stock Split

  January 24, 2025

• Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants

  January 17, 2025

• Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants

  January 15, 2025

• Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market

  January 3, 2025